Literature DB >> 9750081

Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.

P Cinque, S Casari, D Bertelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9750081     DOI： 10.1056/NEJM199809173391216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

Authors:  P Cinque; C Pierotti; M G Viganò; A Bestetti; C Fausti; D Bertelli; A Lazzarin
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.

Authors:  M D Geschwind; R I Skolasky; W S Royal; J C McArthur
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 3.  Challenges for clinical trials to treat progressive multifocal leukoencephalopathy.

Authors:  David B Clifford
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

4.  JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?

Authors:  Supha Kijpittayarit; Raymund R Razonable
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

Review 5.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

Authors:  Andrea Antinori; Antonella Cingolani; Patrizia Lorenzini; Maria Letizia Giancola; Ilaria Uccella; Simona Bossolasco; Susanna Grisetti; Francesca Moretti; Beniamino Vigo; Marco Bongiovanni; Bruno Del Grosso; Maria Irene Arcidiacono; Giovanni Carlo Fibbia; Maurizio Mena; Maria Grazia Finazzi; Giovanni Guaraldi; Adriana Ammassari; Antonella d'Arminio Monforte; Paola Cinque; Andrea De Luca
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

7.  Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.

Authors:  Pasquale Ferrante; Serena Delbue; Elisabetta Pagani; Roberta Mancuso; Angela Marzocchetti; Elisa Borghi; Renato Maserati; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

8.  Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Authors:  Kenneth R Carson; Scott D Newsome; Ellen J Kim; Nina D Wagner-Johnston; Gloria von Geldern; Craig H Moskowitz; Alison J Moskowitz; Alain H Rook; Pankaj Jalan; Alison W Loren; Daniel Landsburg; Thomas Coyne; Donald Tsai; Dennis W Raisch; LeAnn B Norris; P Brandon Bookstaver; Oliver Sartor; Charles L Bennett
Journal:  Cancer       Date:  2014-04-25       Impact factor: 6.860

9.  Unmasking of PML by HAART: unusual clinical features and the role of IRIS.

Authors:  Navdeesh Sidhu; J Allen McCutchan
Journal:  J Neuroimmunol       Date:  2009-12-04       Impact factor: 3.478

10.  JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Emanuela Branchetti; Simone Bertolacci; Eleonora Tavazzi; Enrico Marchioni; Renato Maserati; Giulia Minnucci; Sara Tremolada; GianLuca Vago; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-11-27       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.